BioSpace News Archive

Press Releases

ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer

March 9, 2026
·
19 min read
Press Releases

enGene Reports First Quarter 2026 Financial Results and Provides Business Update

March 9, 2026
·
14 min read
Press Releases

Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma

March 9, 2026
·
6 min read
Press Releases

Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

March 9, 2026
·
6 min read
Press Releases

Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

March 9, 2026
·
8 min read
Press Releases

United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program

March 9, 2026
·
6 min read
Press Releases

Ionis announces changes to Board of Directors

March 9, 2026
·
5 min read
Press Releases

AN2 Therapeutics Announces $40 Million Private Placement Financing

March 9, 2026
·
2 min read
Press Releases

GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership

March 9, 2026
·
9 min read
Press Releases

Crestone Announces Positive Data from Phase 2 Clinical Trial of CRS3123 for C. difficile Infections Published in The Lancet Infectious Diseases

March 9, 2026
·
8 min read